In hormone-responsive BC cells, this would be achieved through the coordinated recruitment of EZH2 involving ERα-associated multi-molecules complexes to down-regulate pro-apoptotic and/or tumor suppressor genes such as BTG2, thus allowing cell proliferation and invasion reduction. This evidence concerns the gene BTG2 and breast cancer.